JP Morgan Chase
MIRA icon

JP Morgan Chase’s MIRA Pharmaceuticals MIRA Stock Holding History

JP Morgan Chase’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16
Closed -$16 – 7427
2025
Q1 		$16 Buy
+16
New +$18 ﹤0.01% 7156
2023
Q4 		– Sell
-100
Closed -$465 – 7733
2023
Q3 		$465 Buy
+100
New +$571 ﹤0.01% 6736

Other funds holding MIRA

CSI
Cross Staff Investments Pittsford, New York $197M AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

JP Morgan Chase's MIRA Position: Q2 2025 in Review

JP Morgan Chase sold out of MIRA Pharmaceuticals (MIRA) in Q2 2025, closing a stake of 16 shares — an estimated $16 sold.

JP Morgan Chase first reported a position in MIRA in Q3 2023 and held it in 2 quarters. The position peaked at $465 in Q3 2023. 20 funds tracked by Wall St. Rank hold MIRA as of Q2 2025.

  • JP Morgan Chase reported no remaining MIRA Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 16 MIRA Pharmaceuticals shares in Q2 2025, an estimated $16.
  • JP Morgan Chase first reported a position in MIRA Pharmaceuticals in Q3 2023 and held it in 2 quarters.
  • JP Morgan Chase's MIRA Pharmaceuticals position peaked at $465 in Q3 2023.
  • 20 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.